The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function

Anesthesia and Analgesia

Volumn 82, Issue 5, 1996, Pages 909-913

  Tsukamoto, Noboru ^a   Hirabayashi, Yoshihiro ^a   Shimizu, Reiju ^a   Mitsuhata, Hiromasa ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; FLUORIDE; GAMMA GLUTAMYLTRANSFERASE; ISOFLURANE; N ACETYL BETA GLUCOSAMINIDASE; SEVOFLURANE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HUMAN; INHALATION ANESTHESIA; KIDNEY DISEASE; KIDNEY TUBULE FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

EID: 0029936775     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199605000-00003     Document Type: Article

References (21)

1. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity: a study of dose-response in man. JAMA 1973;225:1611-6.
2. Kobayashi Y, Ochiai R, Takeda J, et al. Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. Anesth Analg 1992;74:753-7.
3. Frink EJ Jr, Malan TP Jr, Isner RJ, et al. Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology 1994;80:1019-25.
4. Higuchi H, Sumikura H, Sumita S, et al. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995;83:449-58.
5. Conzen PF, Nuscheler M, Melotte A, et al. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 1995;81:569-75.
6. Carpenter RL, Eger EI II, Johnson BH, et al. The extent of metabolism of inhaled anesthetics in humans. Anesthesiology 1986;65:201-5.
7. Fry BW, Taves DR. Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 1970;75;1020-5.
8. Noto A, Ogawa Y, Mori S, et al. Simple, rapid spectrophotometry of urinary N-Acetyl-β-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem 1983;29:1713-6.
9. Orlowski M, Meister A. γ-Glutamyl-p-nitroanilide: a new convenient substrate for determination and study of L- and D-γ-glutamyltranspeptidase activities. Biochim Biophys Acta 1963;73:679-81.
10. 2-microglobulin by inhibition enzyme immunoassay. J Immunol Methods 1981;40:231-8.
11. Mazze RI, Calverley RK, Smith NT. Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 1977;46:265-71.
12. Katoh T, Ikeda K. The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology 1987;66:301-3.
13. Stevens WC, Dolan WM, Gibbons RT. Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients various ages. Anesthesiology 1975;42:197-200.
14. Deleted in proof.
15. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism. Anesthesiology 1995;82:689-99.
16. Wallin RF, Regan BM, Napoli MD, Stern IJ. Sevoflurane: a new inhalational anesthetic agent. Anesth Analg 1975;54:758-65.
17. Hanaki C, Fujii K, Morio M, Tashima T. Decomposition of sevoflurane by sodalime. Hiroshima J Med Sci 1987;36:61-7.
18. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of compound A in rats: effect of a 3-hour administration. Anesthesiology 1994;80:556-65.
19. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of compound A in rats: effect of increasing duration of administration. Anesthesiology 1994;80:566-73.
20. Bito H, Ikeda K. Plasma inorganic fluoride and intracircuit degradation product concentrations in long-duration, low-flow sevoflurane anesthesia. Anesth Analg 1994;79:946-51.
21. Frink EJ Jr, Isner RJ, Malan TP, et al. Sevoflurane degradation product concentrations with soda lime during prolonged anesthesia. J Clin Anesth 1994;6:239-42.